Search

Author/Creator Berthou, Baptiste

1. A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins. (24th November 2022)

Authors:
Catapano, Alberico L.; Vrablik, Michal; Karpov, Yuri; Berthou, Baptiste; Loy, Megan; Baccara-Dinet, Marie
Journal:
Journal of cardiovascular pharmacology and therapeutics
Issue:
Volume 27(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus. (2nd April 2020)

Authors:
Freemantle, Nick; Mauricio, Didac; Giaccari, Andrea; Bailey, Timothy; Roussel, Ronan; Franco, Denise; Berthou, Baptiste; Pilorget, Valerie; Westerbacka, Jukka; Bosnyak, Zsolt; Bonnemaire, Mireille; Cali, Anna M. G.; Nguyên-Pascal, My-Liên; Penfornis, Alfred; Perez-Maraver, Manuel; Seufert, Jochen...
Journal:
Current medical research and opinion
Issue:
Volume 36:Number 4(2020)
Page Start:
571
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study. (August 2020)

Authors:
Hassanein, Mohamed; Buyukbese, Mehmet Akif; Malek, Rachid; Pilorget, Valérie; Naqvi, Mubarak; Berthou, Baptiste; Shaltout, Inass; Kumar Sahay, Rakesh
Journal:
Diabetes research and clinical practice
Issue:
Volume 166(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗